The first-in-class family medicine product in Ireland has been approved by the Irish Medicines Authority.
The new product, Acid Reflux, was developed by the Mayo Clinic in collaboration with the Northwestern Medicine Group.
“We’re delighted to see our products here in Ireland and to be part of the Irish family medicine community,” Dr Jody Wilson, head of the Mayo clinic, said.
Dr Wilson is one of the main figures behind the launch of the new product.
“It was a real challenge for us to come up with a product that is safe, effective and easy to use,” he said.
“So it’s great that we’ve got a product in the market here and that we’re seeing a positive response from patients.”
It’s a really important time in the treatment of reflux and acid reflux, so the announcement of the first-ever family medicine device in Ireland is great news.
“The device is designed to address the issues of refractory acid refracture, which affects children and adults of all ages.”
Reflux is a chronic condition that can affect anyone, and is often the first indication for an antibiotic or an anti-inflammatory medication.
“People with acid reflex symptoms should be able to take acid refleukes with no side effects and be able enjoy a healthy lifestyle.”
Dr Wilson said the new device has the potential to help thousands of patients with acid, as well as thousands more with acid sensitivity.
“There is a need to get more people with acid intolerance and acid intolerance into treatment as this is the most common type of refraction, with around half of patients suffering from reflux,” he added.
The device was developed to address reflux in children and families.
It includes a nasal cannula which is designed so it can be inserted into the nose and administered to the affected area, along with an external capsule.
It is designed for the prevention of further damage to the mucous membranes in the nasal cavity.
Dr Wilson added that it is important for patients to have access to a device that will address their symptoms, not just treat them.
With more than a million patients in Ireland with acid and reflux conditions, this product will enable us to offer patients with refractive disorders a more effective, safer and more effective treatment option,” he concluded.”
This is why it is so important for us, as family medicine practitioners, to offer people with reflux the tools they need to make their own treatment choices.”
With more than a million patients in Ireland with acid and reflux conditions, this product will enable us to offer patients with refractive disorders a more effective, safer and more effective treatment option,” he concluded.